MOVE logo

MOVE (MOVE) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

MOVE representa a MOVE, una empresa del sector Healthcare con un precio de $14.79 (capitalización de mercado 12M). La acción obtiene una puntuación de 54/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 5 feb 2026
Puntuación de IA de 54/100 MCap 12M Vol 44K

MOVE (MOVE) Resumen de Asistencia Médica y Tuberías

CEOJohn Mastrototaro
Empleados32
Sede CentralPleasanton, CA, US
Año de la oferta pública inicial (OPI)2021

Movano Inc. is pioneering wearable health solutions with its Movano Ring, leveraging innovative radiofrequency technology for comprehensive health monitoring and women-centric design, positioning it at the forefront of personalized preventative healthcare and setting the stage for expansion into continuous glucose monitoring and cuffless blood pressure measurement.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 5 feb 2026

Tesis de Inversión

Investing in Movano Inc. presents a high-risk, high-reward opportunity. The company's focus on wearable health technology, particularly the Movano Ring, addresses a growing market for personalized health monitoring. Successful commercialization of the Movano Ring, coupled with the development of non-invasive glucose monitoring and cuffless blood pressure measurement, could drive significant revenue growth. The investment thesis hinges on the company's ability to secure regulatory approvals, demonstrate clinical validity, and effectively market its products. However, the company's negative profit margin of -3409.6% and gross margin of -270.2% highlight the financial challenges. Investors may want to evaluate the potential for substantial returns against the backdrop of significant financial risks and intense competition. The company's market capitalization of $0.01 billion reflects its early stage and associated risks.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.01 billion indicates the company's small size and potential for high growth but also signifies higher risk.
  • P/E ratio of -62.51 reflects the company's current lack of profitability.
  • Profit margin of -3409.6% highlights significant financial challenges and the need for substantial revenue growth.
  • Gross margin of -270.2% indicates that the cost of goods sold exceeds revenue, necessitating improvements in operational efficiency and pricing strategies.
  • Beta of 0.82 suggests that the stock is less volatile than the overall market.

Competidores y Pares

Fortalezas

  • Innovative radiofrequency sensor technology.
  • Focus on women's health.
  • Potential for non-invasive monitoring solutions.
  • Comprehensive health data integration.

Debilidades

  • Negative profitability and gross margins.
  • Limited financial resources.
  • Small market capitalization.
  • Reliance on successful product development and regulatory approvals.

Catalizadores

  • Upcoming: Regulatory approvals for the Movano Ring and its features.
  • Upcoming: Successful completion of clinical trials for non-invasive glucose monitoring.
  • Upcoming: Strategic partnerships with healthcare providers and insurance companies.
  • Ongoing: Continued development and refinement of the Movano platform.
  • Ongoing: Increasing consumer awareness and adoption of wearable health technology.

Riesgos

  • Potential: Failure to obtain regulatory approvals for new products and features.
  • Potential: Unsuccessful clinical trials for non-invasive monitoring technologies.
  • Ongoing: Intense competition from larger, more established companies.
  • Ongoing: Limited financial resources and potential need for additional funding.
  • Ongoing: Risk of technological obsolescence and the need for continuous innovation.

Oportunidades de crecimiento

  • Commercialization of the Movano Ring: The successful launch and market adoption of the Movano Ring represent a significant growth opportunity. The ring's comprehensive health monitoring capabilities, coupled with its women-centric design, could attract a substantial customer base. The wearable health tech market is projected to reach $30 billion by 2028, providing a large addressable market for Movano. The timeline for widespread adoption depends on regulatory approvals and effective marketing strategies. A key competitive advantage lies in the ring's unique radiofrequency-based sensor technology.
  • Expansion into Continuous Glucose Monitoring (CGM): The development of non-invasive CGM capabilities presents a substantial growth opportunity. The global CGM market is expected to reach $10 billion by 2027, driven by the increasing prevalence of diabetes and the demand for convenient monitoring solutions. Movano's non-invasive approach could differentiate it from existing CGM technologies that require skin punctures. The timeline for commercialization depends on successful clinical trials and regulatory clearance. A competitive advantage could be the integration of CGM data with the Movano Ring's existing health metrics.
  • Development of Cuffless Blood Pressure Monitoring: Integrating cuffless blood pressure monitoring into the Movano platform offers another significant growth avenue. The market for blood pressure monitoring devices is substantial, with a growing demand for convenient and accurate solutions. Movano's cuffless technology could provide a more user-friendly alternative to traditional blood pressure cuffs. The timeline for commercialization depends on achieving clinical accuracy and regulatory approval. A competitive advantage lies in the potential for continuous and unobtrusive blood pressure monitoring.
  • Strategic Partnerships and Collaborations: Forming strategic partnerships with healthcare providers, insurance companies, and technology firms could accelerate market penetration and expand Movano's reach. Collaborations with healthcare providers could facilitate clinical validation and adoption of Movano's products. Partnerships with insurance companies could drive reimbursement and increase affordability for consumers. Collaborations with technology firms could enhance the platform's capabilities and integration with other health and wellness ecosystems. The timeline for establishing these partnerships depends on successful product development and market traction.
  • Geographic Expansion: Expanding into new geographic markets represents a long-term growth opportunity. The global market for wearable health technology is growing rapidly, with significant potential in emerging economies. Adapting the Movano Ring and its associated services to meet the specific needs and preferences of different regions could drive international growth. The timeline for geographic expansion depends on securing regulatory approvals and establishing distribution channels in new markets. A key consideration is tailoring the product and marketing strategies to resonate with local cultures and healthcare systems.

Oportunidades

  • Growing market for wearable health technology.
  • Increasing demand for non-invasive monitoring solutions.
  • Potential for strategic partnerships and collaborations.
  • Expansion into new geographic markets.

Amenazas

  • Intense competition from established medical device companies.
  • Regulatory hurdles and clinical trial risks.
  • Technological obsolescence.
  • Economic downturns affecting consumer spending.

Ventajas competitivas

  • Proprietary radiofrequency sensor technology.
  • Focus on women-centric design and features.
  • Integration of multiple health monitoring capabilities into a single device.
  • Potential for non-invasive glucose and blood pressure monitoring.

Acerca de MOVE

Movano Inc., founded in 2018 and based in Pleasanton, California, is a healthcare company focused on developing a platform that converges medical technology and consumer devices. Originally named Maestro Sensors Inc., the company rebranded to Movano Inc. to reflect its innovative approach to healthcare solutions. Movano's core technology revolves around radiofrequency (RF) technology, which enables the creation of miniaturized sensors suitable for wearable devices and other small form factors. Their primary product is the Movano Ring, a wearable device designed to monitor various health metrics, including heart rate, heart rate variability, sleep patterns, respiration rate, temperature, blood oxygen saturation, and activity levels such as steps and calories burned. The Movano Ring also incorporates features and design elements specifically tailored for women's health. Beyond the Movano Ring, the company is actively developing non-invasive continuous glucose monitoring (CGM) and cuffless blood pressure monitoring capabilities to further enhance its technology platform. These advancements aim to provide users with comprehensive and convenient health insights, positioning Movano as a key player in the evolving landscape of preventative and personalized healthcare.

Qué hacen

  • Develop wearable medical devices.
  • Utilize radiofrequency technology for health monitoring.
  • Manufacture the Movano Ring for comprehensive health metrics tracking.
  • Focus on women-centric design and features.
  • Develop non-invasive continuous glucose monitoring (CGM) technology.
  • Develop cuffless blood pressure monitoring technology.
  • Integrate health data into a unified platform.

Modelo de Negocio

  • Direct sales of the Movano Ring to consumers.
  • Potential subscription-based services for data analytics and personalized insights.
  • Partnerships with healthcare providers for remote patient monitoring.
  • Licensing of radiofrequency sensor technology.

Contexto de la Industria

Movano Inc. operates within the rapidly expanding medical device sector, specifically targeting the wearable health technology market. This market is driven by increasing consumer interest in personal health monitoring and preventative care. The competitive landscape includes established medical device companies and emerging technology firms. Key trends include the development of non-invasive monitoring technologies and the integration of AI for personalized health insights. Movano's success depends on its ability to differentiate its products through technological innovation, user-friendly design, and clinical validation. Competitors include ACON Laboratories, American Medical ID, Biolargo Inc., Bioxcel Therapeutics Inc., and G Medical Innovations Holdings Ltd.

Clientes Clave

  • Health-conscious individuals seeking proactive health monitoring.
  • Women interested in health tracking tailored to their needs.
  • Individuals with diabetes or at risk of developing diabetes.
  • Individuals with hypertension or at risk of developing hypertension.
Confianza de la IA: 70% Actualizado: 5 feb 2026

Finanzas

Gráfico e información

Precio de la acción de MOVE (MOVE): $14.79 (+0.44, +3.07%)

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para MOVE.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para MOVE.

MoonshotScore

54/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de MOVE en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Lo Que los Inversores Preguntan Sobre MOVE (MOVE)

¿Cuáles son los factores clave para evaluar MOVE?

MOVE (MOVE) actualmente tiene una puntuación IA de 54/100, indicando puntuación moderada. Fortaleza clave: Innovative radiofrequency sensor technology.. Riesgo principal a monitorear: Potential: Failure to obtain regulatory approvals for new products and features.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de MOVE?

MOVE actualmente puntúa 54/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de MOVE?

Los precios de MOVE se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre MOVE?

La cobertura de analistas para MOVE incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en MOVE?

Las categorías de riesgo para MOVE incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Failure to obtain regulatory approvals for new products and features.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de MOVE?

La relación P/E para MOVE compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está MOVE sobrevalorada o infravalorada?

Determinar si MOVE (MOVE) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de MOVE?

MOVE (MOVE) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Information is based on available data and may be subject to change.
  • Financial metrics are as of the latest available data and may not reflect current performance.
  • Investment decisions should be based on individual risk tolerance and due diligence.
Fuentes de datos

Popular Stocks